To view this email as a web page, click here.
 
Pharma exec defends 400% price hike
Reminiscent of former Turing Pharmaceuticals CEO Martin Shrekli, a different pharma executive defended his company's 400% price hike on an antibiotic.
Read more
 
FDA clears new type of leukemia treatment
FDA okayed a first-of-its-kind treatment for hairy cell leukemia (HCL).
Read more
 
Deadly infection linked to common diabetes drugs
FDA is warning that this deadly infection has been reported in a widely used class of diabetes drugs.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.